New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Dual checkpoint inhibitor blockade shows promise as first-line and salvage therapy for Merkel cell carcinoma patients

Dual checkpoint inhibitor blockade shows promise as first-line and salvage therapy for Merkel cell carcinoma patients

byH. Lee Moffitt Cancer Center & Research InstituteMicrograph of a lung primary small cell carcinoma, a type of carcinoma. Credit: WikipediaMerkel cell carcinoma is a rare but aggressive for
Oncology January 04,2024
Dual checkpoint inhibitor blockade shows promise as first-line and salvage therapy for Merkel cell carcinoma patients

Dual checkpoint inhibitor blockade shows promise as first-line and salvage therapy for Merkel cell carcinoma patients

byH. Lee Moffitt Cancer Center & Research InstituteMicrograph of a lung primary small cell carcinoma, a type of carcinoma. Credit: WikipediaMerkel cell carcinoma is a rare but aggressive for
Oncology January 04,2024
Two-pronged immunotherapy eliminates metastatic breast cancer in mice

Two-pronged immunotherapy eliminates metastatic breast cancer in mice

by Julia Evangelou Strait,Washington University School of MedicineResearchers at Washington University School of Medicine in St. Louis have identified a way to sensitize metastatic breast cancer
Oncology January 04,2024
Two-pronged immunotherapy eliminates metastatic breast cancer in mice

Two-pronged immunotherapy eliminates metastatic breast cancer in mice

by Julia Evangelou Strait,Washington University School of MedicineResearchers at Washington University School of Medicine in St. Louis have identified a way to sensitize metastatic breast cancer
Oncology January 04,2024
Twin study confirms childhood leukemia starts in the womb and could help guide screening when only one twin is affected

Twin study confirms childhood leukemia starts in the womb and could help guide screening when only one twin is affected

byInstitute of Cancer ResearchPre-leukaemic cells in blood of the healthy co-twin of a patient with t(9;22) ALL (pair 3A/B). A FISH for BCR::ABL1 translocation in PB mononuclear cells from twin
Pediatrics January 04,2024
Twin study confirms childhood leukemia starts in the womb and could help guide screening when only one twin is affected

Twin study confirms childhood leukemia starts in the womb and could help guide screening when only one twin is affected

byInstitute of Cancer ResearchPre-leukaemic cells in blood of the healthy co-twin of a patient with t(9;22) ALL (pair 3A/B). A FISH for BCR::ABL1 translocation in PB mononuclear cells from twin
Pediatrics January 04,2024
Dual-targeting CAR NK cells can prevent cell dysfunction and tumor escape

Dual-targeting CAR NK cells can prevent cell dysfunction and tumor escape

byUniversity of Texas M. D. Anderson Cancer CenterKaty Rezvani, M.D., Ph.D., working in her laboratory. Credit: MD Anderson Cancer CenterResearchers at The University of Texas MD Anderson Cancer
Breakthroughs January 04,2024
Dual-targeting CAR NK cells can prevent cell dysfunction and tumor escape

Dual-targeting CAR NK cells can prevent cell dysfunction and tumor escape

byUniversity of Texas M. D. Anderson Cancer CenterKaty Rezvani, M.D., Ph.D., working in her laboratory. Credit: MD Anderson Cancer CenterResearchers at The University of Texas MD Anderson Cancer
Breakthroughs January 04,2024
Aging and cancer hallmarks as therapeutic targets

Aging and cancer hallmarks as therapeutic targets

by Compuscript LtdCrosstalk between aging and cancer hallmarks. (a) Aging hallmarks are categorized into five groups based on correlation with cancer hallmarks. (b) Hallmarks shared between aging and
Oncology January 04,2024
Aging and cancer hallmarks as therapeutic targets

Aging and cancer hallmarks as therapeutic targets

by Compuscript LtdCrosstalk between aging and cancer hallmarks. (a) Aging hallmarks are categorized into five groups based on correlation with cancer hallmarks. (b) Hallmarks shared between aging and
Oncology January 04,2024
Digital breast tomosynthesis improves cancer screening in community settings

Digital breast tomosynthesis improves cancer screening in community settings

byRadiological Society of North AmericaCredit: Unsplash/CC0 Public DomainResearchers have found that digital breast tomosynthesis (DBT) has improved breast cancer screening performance in commun
Medical imageology January 04,2024
Digital breast tomosynthesis improves cancer screening in community settings

Digital breast tomosynthesis improves cancer screening in community settings

byRadiological Society of North AmericaCredit: Unsplash/CC0 Public DomainResearchers have found that digital breast tomosynthesis (DBT) has improved breast cancer screening performance in commun
Medical imageology January 04,2024
Preoperative immunotherapy for mesothelioma shows favorable outcomes

Preoperative immunotherapy for mesothelioma shows favorable outcomes

by Dipali Pathak,Baylor College of MedicineCredit: Pixabay/CC0 Public DomainIn a study published recently in the journalClinical Cancer Research, researchers at Baylor College of Medicine
Oncology January 04,2024
Preoperative immunotherapy for mesothelioma shows favorable outcomes

Preoperative immunotherapy for mesothelioma shows favorable outcomes

by Dipali Pathak,Baylor College of MedicineCredit: Pixabay/CC0 Public DomainIn a study published recently in the journalClinical Cancer Research, researchers at Baylor College of Medicine
Oncology January 04,2024
Chemotherapy before surgery can improve survival rates in pancreatic cancer patients

Chemotherapy before surgery can improve survival rates in pancreatic cancer patients

byUniversity of LiverpoolCredit: CC0 Public DomainTreating pancreatic cancer patients with chemotherapy before surgery significantly improved 1-year survival rates compared to immediate surgery,
Oncology January 04,2024
Chemotherapy before surgery can improve survival rates in pancreatic cancer patients

Chemotherapy before surgery can improve survival rates in pancreatic cancer patients

byUniversity of LiverpoolCredit: CC0 Public DomainTreating pancreatic cancer patients with chemotherapy before surgery significantly improved 1-year survival rates compared to immediate surgery,
Oncology January 04,2024
First integrated human lung cell atlas provides insights into lung diseases

First integrated human lung cell atlas provides insights into lung diseases

byWellcome Trust Sanger InstituteCredit: CC0 Public DomainThe largest and most comprehensive cell map of the human lung is published inNature Medicineon June 8. Revealing the great d
Pulmonology January 04,2024
First integrated human lung cell atlas provides insights into lung diseases

First integrated human lung cell atlas provides insights into lung diseases

byWellcome Trust Sanger InstituteCredit: CC0 Public DomainThe largest and most comprehensive cell map of the human lung is published inNature Medicineon June 8. Revealing the great d
Pulmonology January 04,2024
New hormone therapies before surgery may improve outcomes in high-risk prostate cancer

New hormone therapies before surgery may improve outcomes in high-risk prostate cancer

byWolters Kluwer HealthTime to BCR in the neo-RP and RP cohorts after IPTW. The number of participants at risk are based on unweighted population. Credit:Journal of Urology(2022). DO
Oncology January 04,2024
New hormone therapies before surgery may improve outcomes in high-risk prostate cancer

New hormone therapies before surgery may improve outcomes in high-risk prostate cancer

byWolters Kluwer HealthTime to BCR in the neo-RP and RP cohorts after IPTW. The number of participants at risk are based on unweighted population. Credit:Journal of Urology(2022). DO
Oncology January 04,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com